相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox Status to Potentiate Radiotherapy
Shun Kishimoto et al.
ANTIOXIDANTS & REDOX SIGNALING (2021)
Targeting hypoxic tumor microenvironment in pancreatic cancer
Jinxin Tao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4/KDM5A-mediated histone methylation modification changes in a HIF1A-independent manner
Hongzhen Li et al.
CLINICAL EPIGENETICS (2021)
Relevance of Immune Infiltration and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma Subtypes
Rong Liu et al.
FRONTIERS IN ONCOLOGY (2021)
Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer
Joan M. Romero et al.
CLINICAL CANCER RESEARCH (2020)
Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy
Raefa Abou Khouzam et al.
SEMINARS IN CANCER BIOLOGY (2020)
Divergent mutational processes distinguish hypoxic and normoxic tumours
Vinayak Bhandari et al.
NATURE COMMUNICATIONS (2020)
The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis
Adile Orhan et al.
EUROPEAN JOURNAL OF CANCER (2020)
Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis
Ashutosh Tiwari et al.
GASTROENTEROLOGY (2020)
Identification of a Hypoxia-Associated Signature for Lung Adenocarcinoma
Zhuomao Mo et al.
FRONTIERS IN GENETICS (2020)
Resolving the HIF paradox in pancreatic cancer
Natividad R. Fuentes et al.
CANCER LETTERS (2020)
Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma
Dajia Liu et al.
BIOMEDICINES (2020)
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
Hongwei Du et al.
CANCER CELL (2019)
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases
Ashton A. Connor et al.
CANCER CELL (2019)
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer
Tara N. Fujimoto et al.
CANCER RESEARCH (2019)
Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia
Paul C. McDonald et al.
GASTROENTEROLOGY (2019)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
Shawn C. Chafe et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis
Zheng-Lin Ou et al.
RNA BIOLOGY (2019)
Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
Muhammad Zaeem Noman et al.
CELLS (2019)
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
S. K. Daniel et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
Zishuo I. Hu et al.
CLINICAL CANCER RESEARCH (2018)
B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity
Kimio Yonesaka et al.
CLINICAL CANCER RESEARCH (2018)
The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis
He-Li Gao et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2018)
TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer
Jinfeng Xiang et al.
CELL DEATH & DISEASE (2018)
Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer
Andrew J. Rech et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
Lingjian Yang et al.
EBIOMEDICINE (2018)
Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
Kentaro Inamura et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
Francesco Puleo et al.
GASTROENTEROLOGY (2018)
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
David Balli et al.
CLINICAL CANCER RESEARCH (2017)
Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS
Esko A. Kautto et al.
ONCOTARGET (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
New B7 Family Checkpoints in Human Cancers
Ling Ni et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A Combination of Radiation and the Hypoxia-Activated Prodrug Evofosfamide (TH-302) is Efficacious against a Human Orthotopic Pancreatic Tumor Model
Carla Hajj et al.
TRANSLATIONAL ONCOLOGY (2017)
B7-H3 combats apoptosis induced by chemotherapy by delivering signals to pancreatic cancer
Dongbao Li et al.
ONCOTARGET (2017)
T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma
Ingunn M. Stromnes et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
Sacha Gnjatic et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Landscape of Microsatellite Instability Across 39 Cancer Types
Russell Bonneville et al.
JCO PRECISION ONCOLOGY (2017)
Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia
Kyoung Eun Lee et al.
CANCER DISCOVERY (2016)
Hypoxia induces TWIST-activated epithelial-mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice
Shi Chen et al.
CANCER LETTERS (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302
Ines Lohse et al.
ONCOTARGET (2016)
Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma
Na Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
Bryan W. Miller et al.
EMBO MOLECULAR MEDICINE (2015)
Hypoxia-mediated immune evasion of pancreatic carcinoma cells
Yebin Lu et al.
MOLECULAR MEDICINE REPORTS (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Stephen M. Hatfield et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: A meta-analysis
Long-Yun Ye et al.
PANCREATOLOGY (2014)
Assessment of Hypoxia in the Stroma of Patient-Derived Pancreatic Tumor Xenografts
Ines Lohse et al.
CANCERS (2014)
PanIN-Specific Regulation of Wnt Signaling by HIF2α during Early Pancreatic Tumorigenesis
Angela Criscimanna et al.
CANCER RESEARCH (2013)
B7-H3 overexpression in pancreatic cancer promotes tumor progression
Xin Zhao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Silencing of B7-H3 increases gemcitabine sensitivity by promoting apoptosis in pancreatic carcinoma
Xin Zhao et al.
ONCOLOGY LETTERS (2013)
Hypoxia-Inducible Factors in Physiology and Medicine
Gregg L. Semenza
CELL (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer
Nina V. Chaika et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer
Kasper Toustrup et al.
CANCER RESEARCH (2011)
Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic Cancer
Qing Chang et al.
CANCER RESEARCH (2011)
Hypoxia Induces Escape from Innate Immunity in Cancer Cells via Increased Expression of ADAM10: Role of Nitric Oxide
Ivraym B. Barsoum et al.
CANCER RESEARCH (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
F. M. Buffa et al.
BRITISH JOURNAL OF CANCER (2010)
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Richard E. Royal et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers
Stuart C. Winter et al.
CANCER RESEARCH (2007)
Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer
Takeo Nomi et al.
CLINICAL CANCER RESEARCH (2007)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
